D-0865-2016 Class I Ongoing
FDA drug recall D-0865-2016 was initiated by Hospira Inc. on Mar 18, 2016 and is designated Class I. Reason for recall: Presence of Particulate Matter: particulate matter identified as an insect in one vial. The recall status is ongoing. Affected quantity: 72,000 units.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 1, 2016
- Initiation Date
- Mar 18, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 72,000 units
Product description
8.4% Sodium Bicarbonate Injection, USP 50mEq (1mEq/mL), 4.2 grams (84 mg/mL), 50 mL, Rx only, Hospira Inc, Lake Forest, IL 60045, NDC 0409-6625-02
Reason for recall
Presence of Particulate Matter: particulate matter identified as an insect in one vial.
Distribution pattern
Nationwide
Code information
Lot # 56-148-EV, Exp 8/1/2017
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0865-2016
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Hospira Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.